Exosome-sheathed ROS-responsive nanogel to improve targeted therapy in perimenopausal depression

Abstract The development of natural membranes as coatings for nanoparticles to traverse the blood-brain barrier (BBB) presents an effective approach for treating central nervous system (CNS) disorders. In this study, we have designed a nanogel loaded with PACAP and estrogen (E2), sheathed with exoso...

Full description

Bibliographic Details
Main Authors: Yue Hu, Min Zhao, Hui Wang, Yang Guo, Xiaolan Cheng, Tong Zhao, Hanqing Wang, Yafeng Zhang, Yong Ma, Weiwei Tao
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Journal of Nanobiotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12951-023-02005-y
_version_ 1797556732680994816
author Yue Hu
Min Zhao
Hui Wang
Yang Guo
Xiaolan Cheng
Tong Zhao
Hanqing Wang
Yafeng Zhang
Yong Ma
Weiwei Tao
author_facet Yue Hu
Min Zhao
Hui Wang
Yang Guo
Xiaolan Cheng
Tong Zhao
Hanqing Wang
Yafeng Zhang
Yong Ma
Weiwei Tao
author_sort Yue Hu
collection DOAJ
description Abstract The development of natural membranes as coatings for nanoparticles to traverse the blood-brain barrier (BBB) presents an effective approach for treating central nervous system (CNS) disorders. In this study, we have designed a nanogel loaded with PACAP and estrogen (E2), sheathed with exosomes and responsive to reactive oxygen species (ROS), denoted as HA NGs@exosomes. The objective of this novel design is to serve as a potent drug carrier for the targeted treatment of perimenopausal depression. The efficient cellular uptake and BBB penetration of HA NGs@exosomes has been demonstrated in vitro and in vivo. Following intranasal intervention with HA NGs@exosomes, ovariectomized mice under chronic unpredictable mild stress (CUMS) have shown improved behavioral performance, indicating that HA NGs@exosomes produced a rapid-onset antidepressant effect. Moreover, HA NGs@exosomes exhibit notable antioxidant and anti-inflammatory properties and may regulate the expression of pivotal proteins in the PACAP/PAC1 pathway to promote synaptic plasticity. Our results serve as a proof-of-concept for the utility of exosome-sheathed ROS-responsive nanogel as a promising drug carrier for the treatment of perimenopausal depression. Graphical Abstract
first_indexed 2024-03-10T17:07:03Z
format Article
id doaj.art-96b637f015234557964ef04c113b7724
institution Directory Open Access Journal
issn 1477-3155
language English
last_indexed 2024-03-10T17:07:03Z
publishDate 2023-08-01
publisher BMC
record_format Article
series Journal of Nanobiotechnology
spelling doaj.art-96b637f015234557964ef04c113b77242023-11-20T10:47:57ZengBMCJournal of Nanobiotechnology1477-31552023-08-0121112210.1186/s12951-023-02005-yExosome-sheathed ROS-responsive nanogel to improve targeted therapy in perimenopausal depressionYue Hu0Min Zhao1Hui Wang2Yang Guo3Xiaolan Cheng4Tong Zhao5Hanqing Wang6Yafeng Zhang7Yong Ma8Weiwei Tao9Jiangsu CM Clinical Innovation Center of Degenerative Bone & Joint Disease, Wuxi TCM Hospital Affiliated to Nanjing University of Chinese MedicineJiangsu CM Clinical Innovation Center of Degenerative Bone & Joint Disease, Wuxi TCM Hospital Affiliated to Nanjing University of Chinese MedicineSchool of pharmacology, Nanjing University of Chinese MedicineJiangsu CM Clinical Innovation Center of Degenerative Bone & Joint Disease, Wuxi TCM Hospital Affiliated to Nanjing University of Chinese MedicineJiangsu CM Clinical Innovation Center of Degenerative Bone & Joint Disease, Wuxi TCM Hospital Affiliated to Nanjing University of Chinese MedicineJiangsu CM Clinical Innovation Center of Degenerative Bone & Joint Disease, Wuxi TCM Hospital Affiliated to Nanjing University of Chinese MedicineSchool of pharmacology, Ningxia Medical UniversityJiangsu CM Clinical Innovation Center of Degenerative Bone & Joint Disease, Wuxi TCM Hospital Affiliated to Nanjing University of Chinese MedicineJiangsu CM Clinical Innovation Center of Degenerative Bone & Joint Disease, Wuxi TCM Hospital Affiliated to Nanjing University of Chinese MedicineJiangsu CM Clinical Innovation Center of Degenerative Bone & Joint Disease, Wuxi TCM Hospital Affiliated to Nanjing University of Chinese MedicineAbstract The development of natural membranes as coatings for nanoparticles to traverse the blood-brain barrier (BBB) presents an effective approach for treating central nervous system (CNS) disorders. In this study, we have designed a nanogel loaded with PACAP and estrogen (E2), sheathed with exosomes and responsive to reactive oxygen species (ROS), denoted as HA NGs@exosomes. The objective of this novel design is to serve as a potent drug carrier for the targeted treatment of perimenopausal depression. The efficient cellular uptake and BBB penetration of HA NGs@exosomes has been demonstrated in vitro and in vivo. Following intranasal intervention with HA NGs@exosomes, ovariectomized mice under chronic unpredictable mild stress (CUMS) have shown improved behavioral performance, indicating that HA NGs@exosomes produced a rapid-onset antidepressant effect. Moreover, HA NGs@exosomes exhibit notable antioxidant and anti-inflammatory properties and may regulate the expression of pivotal proteins in the PACAP/PAC1 pathway to promote synaptic plasticity. Our results serve as a proof-of-concept for the utility of exosome-sheathed ROS-responsive nanogel as a promising drug carrier for the treatment of perimenopausal depression. Graphical Abstracthttps://doi.org/10.1186/s12951-023-02005-yExosomeNanogelPerimenopausal DepressionPACAPEstrogen
spellingShingle Yue Hu
Min Zhao
Hui Wang
Yang Guo
Xiaolan Cheng
Tong Zhao
Hanqing Wang
Yafeng Zhang
Yong Ma
Weiwei Tao
Exosome-sheathed ROS-responsive nanogel to improve targeted therapy in perimenopausal depression
Journal of Nanobiotechnology
Exosome
Nanogel
Perimenopausal Depression
PACAP
Estrogen
title Exosome-sheathed ROS-responsive nanogel to improve targeted therapy in perimenopausal depression
title_full Exosome-sheathed ROS-responsive nanogel to improve targeted therapy in perimenopausal depression
title_fullStr Exosome-sheathed ROS-responsive nanogel to improve targeted therapy in perimenopausal depression
title_full_unstemmed Exosome-sheathed ROS-responsive nanogel to improve targeted therapy in perimenopausal depression
title_short Exosome-sheathed ROS-responsive nanogel to improve targeted therapy in perimenopausal depression
title_sort exosome sheathed ros responsive nanogel to improve targeted therapy in perimenopausal depression
topic Exosome
Nanogel
Perimenopausal Depression
PACAP
Estrogen
url https://doi.org/10.1186/s12951-023-02005-y
work_keys_str_mv AT yuehu exosomesheathedrosresponsivenanogeltoimprovetargetedtherapyinperimenopausaldepression
AT minzhao exosomesheathedrosresponsivenanogeltoimprovetargetedtherapyinperimenopausaldepression
AT huiwang exosomesheathedrosresponsivenanogeltoimprovetargetedtherapyinperimenopausaldepression
AT yangguo exosomesheathedrosresponsivenanogeltoimprovetargetedtherapyinperimenopausaldepression
AT xiaolancheng exosomesheathedrosresponsivenanogeltoimprovetargetedtherapyinperimenopausaldepression
AT tongzhao exosomesheathedrosresponsivenanogeltoimprovetargetedtherapyinperimenopausaldepression
AT hanqingwang exosomesheathedrosresponsivenanogeltoimprovetargetedtherapyinperimenopausaldepression
AT yafengzhang exosomesheathedrosresponsivenanogeltoimprovetargetedtherapyinperimenopausaldepression
AT yongma exosomesheathedrosresponsivenanogeltoimprovetargetedtherapyinperimenopausaldepression
AT weiweitao exosomesheathedrosresponsivenanogeltoimprovetargetedtherapyinperimenopausaldepression